Further analyses are needed to identify the mechanism underlying the cancer-specific hnRNP H1–SGPL1 mRNA interaction, such as pre- and/or post-transcriptional alterations of hnRNP H1 and/or SGPL1, and to identify other pathways associated with cell growth promoted by hnRNP H1–SPGPL1, including microRNAs and long-ncRNA pathways. The gene discussed is SGPL1; the disease is cancer.